HCU: Can VHVs Trained in ICCM Improve Care for Children


This study will assess how the current VHV (VHV=CHW, community health worker) scope can be expanded to include iCCM and if such group interventions can provide improved access to treatment for children.

In rural SW Uganda, can iCCM provided by lay volunteers, increase the proportion of children with diarrhoea receiving ORS/Zn, ARI receiving anti-biotics, and fever/malaria receiving anti-malarials?

Full Title of Study: “Healthy Child Uganda: Can Village Health Volunteers Trained in Integrated Community Case Management of Childhood Illness Improve Access to Care for Africa’s Most Vulnerable Children?”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 2012


  • Other: Training of VHVs in iCCM
    • Village Health Volunteers will be trained in Integrated Community Case Management (iCCM) of childhood illness

Arms, Groups and Cohorts

  • Experimental: Training of VHVs in iCCM
    • In these villages VHVs will be provided with iCCM training and equipped to support iCCM in their villages

Clinical Trial Outcome Measures

Primary Measures

  • Absolute change pre/post intervention (VHV ICCM training) in proportion of U5s receiving (a) antimalarial for fever (b) ORS/Zn for diarrhea (c) Abx for pneumonia
    • Time Frame: pre- (Dec 2010) post- (Dec 2012) intervention (2 years)

Participating in This Clinical Trial

Inclusion Criteria

  • Women living in intervention and comparison villages
  • Mother to at least one child under 59 months old

Exclusion Criteria

-No living child

Gender Eligibility: Female

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University of Calgary
  • Collaborator
    • Mbarara University of Science and Technology
  • Provider of Information About this Clinical Study
    • Principal Investigator: Jennifer L. Brenner, Clinical Associate Professor – University of Calgary
  • Overall Official(s)
    • Samuel Maling, MD, Principal Investigator, Mbarara University of Science and Technology
    • jenn Brenner, MD, Study Director, University of Calgary

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.